Mukka Proteins approves ₹15cr investment for Aqua Marine stake

1 min read     Updated on 13 Jun 2026, 04:37 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Mukka Proteins Limited's board approved a strategic investment of up to ₹15,00,00,000 to acquire a 51% stake in Aqua Marine, a partnership firm manufacturing fish meals and fish oil. The transaction, approved on June 12, 2026, is not a related party transaction and is expected to be completed by September 30, 2026.

powered bylight_fuzz_icon
42554673

*this image is generated using AI for illustrative purposes only.

Mukka Proteins Limited has approved a strategic investment of up to ₹15,00,00,000 to acquire a 51% stake in Aqua Marine, a partnership firm engaged in the manufacturing of fish meals and fish oil. The board approved the proposal at its meeting held on June 12, 2026. The investment will be made through capital contribution in one or more tranches, with an indicative completion timeline of September 30, 2026.

The acquisition is not a related party transaction and does not require any specific governmental or regulatory approvals. Aqua Marine reported a turnover of ₹32,15,07,660 and a profit after tax (PAT) of ₹1,067,656 for the financial year 2024-25. The entity was incorporated on April 1, 2022, and operates solely in India.

Investment Details

Parameter Details
Target Entity Aqua Marine
Stake Acquired 51%
Investment Amount Up to ₹15,00,00,000
Consideration Type Cash
Completion Timeline September 30, 2026

Target Entity Financials

Period Turnover
As on March 2023 ₹1,72,94,750
As on March 2024 ₹54,67,36,135
As on March 2025 ₹32,15,07,660

The company stated that this investment is part of its strategic plans to expand its core business, focusing on capacity expansion and optimization of operational processes. This move is expected to lead to improved production efficiency and a broader market reach.

Historical Stock Returns for Mukka Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
-3.17%-4.07%+1.77%-2.24%-21.50%-44.26%

How will Mukka Proteins fund the ₹15 crore investment, and what impact will this have on its leverage ratios?

What specific operational synergies does Mukka Proteins expect to realize by integrating Aqua Marine's manufacturing capabilities?

How will the acquisition address the volatility in Aqua Marine's turnover, which declined from ₹54.67 crore in FY24 to ₹32.15 crore in FY25?

Mukka Proteins approves Rs 11.10 Cr investment for 51% stake

1 min read     Updated on 13 Jun 2026, 04:32 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Mukka Proteins Limited approved a strategic investment of up to Rs 11.10 crore to acquire a 51% stake in Delta Marine Products, a partnership firm involved in manufacturing fish meal and fish oil. The Board approved the capital contribution on June 12, 2026, with the transaction expected to be completed by September 30, 2026. Delta Marine Products reported a turnover of Rs 28.16 crore for FY 2024-25.

powered bylight_fuzz_icon
42813657

*this image is generated using AI for illustrative purposes only.

Mukka Proteins Limited approved a strategic investment to acquire a 51% stake in Delta Marine Products for an amount not exceeding Rs 11.10 crore. The Board of Directors approved the capital contribution in one or more tranches on June 12, 2026, to expand the company's core business of manufacturing fish meal and fish oil.

The investment targets Delta Marine Products, a partnership firm incorporated on August 12, 2023, operating within the same industry. The acquisition is not a related party transaction and will be settled through cash consideration. The transaction is expected to be completed by September 30, 2026.

Financials of the Target Entity

Delta Marine Products reported a turnover of Rs 28.16 crore for FY 2024-25, a significant increase from Rs 3.64 crore in the previous year. However, the firm posted a loss after tax (PAT) of Rs 19.72 lakh for FY 2024-25.

Metric Value
Turnover (FY 2024-25) Rs 28,16,99,338/-
PAT (FY 2024-25) Rs (19,72,919/-)
Turnover (As on March 2024) Rs 3,64,15,650/-
Date of Incorporation 12-08-2023

Strategic Rationale

The proposed investment aligns with Mukka Proteins 's strategic plans to focus on capacity expansion and optimization of operational processes. The company stated that this move would lead to improved production efficiency and a broader market reach. The target entity operates exclusively in India, manufacturing fish meal and fish oil.

Historical Stock Returns for Mukka Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
-3.17%-4.07%+1.77%-2.24%-21.50%-44.26%

How does Mukka Proteins plan to address the target entity's recent profitability issues post-acquisition?

What specific operational synergies are expected to improve production efficiency following this integration?

Will this acquisition trigger further consolidation within the domestic fish meal and fish oil industry?

More News on Mukka Proteins

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:-21.50%